Home > Journals > Minerva Chirurgica > Past Issues > Minerva Chirurgica 2003 August;58(4) > Minerva Chirurgica 2003 August;58(4):479-90

CURRENT ISSUE
 

ARTICLE TOOLS

Reprints

MINERVA CHIRURGICA

A Journal on Surgery


Indexed/Abstracted in: EMBASE, PubMed/MEDLINE, Science Citation Index Expanded (SciSearch), Scopus
Impact Factor 0,877


eTOC

 

REVIEWS  


Minerva Chirurgica 2003 August;58(4):479-90

language: English

Practical management of liver transplant recipients for hepatitis C

Saab S., Busuttil R. W.


PDF  


Hepatitis C is one of the leading indications for liver transplantation. Recipients can expect at least a short-term survival equivalent to other indications for liver transplantation. However, the rates of cirrhosis and decompensation development is substantially faster than those rates seen in non-transplant setting. Advances in antiviral therapy are now associated with a sustained virological response of 20% with combination antiviral with interferon and ribavirin. Higher response rates are expected with utilizing pegylated interferon.

top of page

Publication History

Cite this article as

Corresponding author e-mail